These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 32428014

  • 1. Indexation of left ventricular mass to predict adverse clinical outcomes in pre-dialysis patients with chronic kidney disease: KoreaN cohort study of the outcome in patients with chronic kidney disease.
    Lee SW, Min HK, Chae DW, Oh KH, Ahn C, Chung W, Lee J, Kim YS, Sung SA, Representing the KNOW-CKD Study Group.
    PLoS One; 2020; 15(5):e0233310. PubMed ID: 32428014
    [Abstract] [Full Text] [Related]

  • 2. Indexation criteria of ventricular mass and predictive role of blood pressure and body composition.
    Ferrara LA, Vaccaro O, Cardoni O, Laurenzi M, Mancini M, Zanchetti A.
    Am J Hypertens; 2005 Oct; 18(10):1282-7. PubMed ID: 16202849
    [Abstract] [Full Text] [Related]

  • 3. Incidence of left ventricular hypertrophy in children with kidney disease: impact of method of indexation of left ventricular mass.
    Simpson JM, Savis A, Rawlins D, Qureshi S, Sinha MD.
    Eur J Echocardiogr; 2010 Apr; 11(3):271-7. PubMed ID: 20015849
    [Abstract] [Full Text] [Related]

  • 4. Differences in cardiac structure assessed by echocardiography between renal transplant recipients and chronic kidney disease patients.
    Dounousi E, Mitsis M, Naka KK, Pappas C, Lakkas L, Harisis C, Pappas K, Koutlas V, Tzalavra I, Spanos G, Michalis LK, Siamopoulos KC.
    Transplant Proc; 2014 Nov; 46(9):3194-8. PubMed ID: 25420857
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass.
    Vitale G, Galderisi M, Pivonello R, Spinelli L, Ciccarelli A, de Divitiis O, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):343-9. PubMed ID: 15009000
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
    Ruebner RL, Ng D, Mitsnefes M, Foster BJ, Meyers K, Warady B, Furth SL.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1962-1968. PubMed ID: 27630183
    [Abstract] [Full Text] [Related]

  • 7. Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass?
    Gosse P, Jullien V, Jarnier P, Lemetayer P, Clementy J.
    J Hum Hypertens; 1999 Aug 07; 13(8):505-9. PubMed ID: 10455470
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of left ventricular mass normalized to different body size indexes: findings from the PAMELA population.
    Cuspidi C, Facchetti R, Bombelli M, Sala C, Tadic M, Grassi G, Mancia G.
    J Hypertens; 2015 May 07; 33(5):1082-9. PubMed ID: 25668356
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular mass regression after aortic valve replacement: Sex differences or effect of different methods of indexation?
    Del Bene MR, Barletta G, Venditti F, Di Mario C, Blanzola C, Stefàno P.
    Echocardiography; 2019 Feb 07; 36(2):219-228. PubMed ID: 30520149
    [Abstract] [Full Text] [Related]

  • 10. Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives?
    Cuspidi C, Meani S, Negri F, Giudici V, Valerio C, Sala C, Zanchetti A, Mancia G.
    J Hum Hypertens; 2009 Nov 07; 23(11):728-34. PubMed ID: 19322202
    [Abstract] [Full Text] [Related]

  • 11. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis.
    Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS.
    J Am Soc Nephrol; 2001 Dec 07; 12(12):2768-2774. PubMed ID: 11729247
    [Abstract] [Full Text] [Related]

  • 12. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.
    Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS.
    Kidney Int; 2004 Apr 07; 65(4):1492-8. PubMed ID: 15086493
    [Abstract] [Full Text] [Related]

  • 13. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
    Kim ED, Sozio SM, Estrella MM, Jaar BG, Shafi T, Meoni LA, Kao WH, Lima JA, Parekh RS.
    BMC Nephrol; 2015 Aug 07; 16():131. PubMed ID: 26249016
    [Abstract] [Full Text] [Related]

  • 14. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.
    Patel RK, Oliver S, Mark PB, Powell JR, McQuarrie EP, Traynor JP, Dargie HJ, Jardine AG.
    Clin J Am Soc Nephrol; 2009 Sep 07; 4(9):1477-1483. PubMed ID: 19713289
    [Abstract] [Full Text] [Related]

  • 15. Relation of left ventricular mass and concentric remodeling to extent of coronary artery disease by computed tomography in patients without left ventricular hypertrophy: ROMICAT study.
    Truong QA, Toepker M, Mahabadi AA, Bamberg F, Rogers IS, Blankstein R, Brady TJ, Nagurney JT, Hoffmann U.
    J Hypertens; 2009 Dec 07; 27(12):2472-82. PubMed ID: 19696685
    [Abstract] [Full Text] [Related]

  • 16. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study.
    de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, Lee ET, Devereux RB, Strong Heart Study Investigators.
    Am J Hypertens; 2005 Feb 07; 18(2 Pt 1):191-6. PubMed ID: 15752946
    [Abstract] [Full Text] [Related]

  • 17. Subclassification of left ventricular hypertrophy based on dilation stratifies coronary artery disease patients with distinct risk.
    Huang BT, Peng Y, Liu W, Zhang C, Huang FY, Wang PJ, Zuo ZL, Liao YB, Chai H, Li Q, Zhao ZG, Luo XL, Ren X, Huang KS, Meng QT, Chen C, Huang DJ, Chen M.
    Eur J Clin Invest; 2014 Oct 07; 44(10):893-901. PubMed ID: 25104141
    [Abstract] [Full Text] [Related]

  • 18. Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging.
    Arnold R, Schwendinger D, Jung S, Pohl M, Jung B, Geiger J, Gimpel C.
    Pediatr Nephrol; 2016 Feb 07; 31(2):255-65. PubMed ID: 26342304
    [Abstract] [Full Text] [Related]

  • 19. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors in Thai elderly men and women.
    Chantra S, Bhuthong B.
    J Med Assoc Thai; 2000 Sep 07; 83(9):1082-94. PubMed ID: 11075977
    [Abstract] [Full Text] [Related]

  • 20. Influence of the Method of Definition on the Prevalence of Left-Ventricular Hypertrophy in Children with Chronic Kidney Disease: Data from the Know-Ped CKD Study.
    Cho H, Choi HJ, Kang HG, Ha IS, Cheong HI, Han KH, Kim SH, Cho MH, Shin JI, Lee JH, Park YS.
    Kidney Blood Press Res; 2017 Sep 07; 42(3):406-415. PubMed ID: 28689198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.